Contract signedUnited Kingdom
Preclinical Research and specialist toxicology services and portfolio of drug-development products
- Published
- Published 12 May 2025
Overview
To provide a comprehensive, integrated portfolio of drug-development products and services, preclinical research and toxicology studies to support ongoing research for anticancer compound CADD522.
Key details
- Country
- United Kingdom
- Status
- Contract signed
- Published
- 12 May 2025
Award outcome
- Award date
- 1 April 2025
- Charles River Laboratories
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
12 May 2025
View notice ↗
Contracting authority
UNIVERSITY OF EAST ANGLIA
BuyerNorwich, United Kingdom
GB-COH: RC000651
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.